Glypican-3 CAR-T cells

glypican-3-specific chimeric antigen receptor T cells · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glypican-3 CAR-T cells, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR) [Phase 1]